SCHEMBL14486281

SCHEMBL14486281

COc1cc(SCCc2ccccc2)cnc1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.44
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ ADRA1D P25100 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14486622 0.87 GCK (0.46) ALDH1A1KMT2ALMNAMAPTHTT
SCHEMBL14485783 0.80 ABCB1 (0.48) ABCB1EGFR
SCHEMBL19493136 0.80 AR (0.48) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL14485742 0.77 L3MBTL1 (0.48) CYP1A2CYP3A4CYP2D6CYP2C19KDM4E
SCHEMBL14486615 0.76 PIK3CG (0.44) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL14485803 0.76 MAPT (0.44) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL14486608 0.74 MAPT (0.45) CYP1A2CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL14486022 0.74 MAPT (0.42) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL14486460 0.74 MAPT (0.46) ALDH1A1KMT2ALMNAMAPTHTT
SCHEMBL14485982 0.73 CXCR1 (0.40) KDM4EALDH1A1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2729449-A1 5- OR 6 - SUBSTITUTED 3 - HYDROXY - 2 ( 1H) - PYRIDINONES AS D-AMINO ACID OXIDASE (DAAO) INHIBITORS IN THERAPY OF DISEASES SUCH AS SCHIZOPHRENIA, COGNITIVE DISORDER AND PAIN Takeda Pharmaceutical Company Limited (JP) 2014-05-14 — — EP disclosed
WO-2013004996-A1 5- OR 6 - SUBSTITUTED 3 - HYDROXY - 2 ( 1H) - PYRIDINONES AS D-AMINO ACID OXIDASE (DAAO) INHIBITORS IN THERAPY OF DISEASES SUCH AS SCHIZOPHRENIA, COGNITIVE DISORDER AND PAIN TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-01-10 — — WO disclosed
Send feedback